Issue link: https://viewer.e-digitaledition.com/i/140434
Therefore, in addition to gathering a thorough patient history, pulmonologists may administer a methacholine challenge test — in which they induce an asthma attack with an airway irritant — to allow definitive diagnosis. Once the disease is identified, medical therapies, including aggressive inhaled corticosteroids and bronchodilators, can be prescribed to help control asthma. Deborah Stahlnecker, DO, Director of Critical Care at St. Luke's University Health Network's Anderson Campus, board-certified in pulmonary and critical care medicine, explains that other medications for allergy management must be prescribed as well because allergies can exacerbate asthma. In tandem with allergy medications, moderate to severe asthmatics with allergies may benefit from Xolair injections once or twice per month as needed, Dr. Stahlnecker says. The Future of Asthma Treatment In addition, this summer, St. Luke's Pulmonary Medicine Department welcomes a leading-edge treatment that significantly improves asthma patients' ability to participate fully in everyday activities. Dr. Stahlnecker says minimally invasive bronchial thermoplasty prevents frequent exacerbations for patients whose conditions have not been managed well by medicine, and it reduces the amount of work, school or other pursuits missed due to asthma attacks. Dr. Bratis explains that the innovative therapy represents a groundbreaking option for asthmatics. "This procedure can make a huge difference in our patients' quality of life," she says. "We've never been able to do anything like this before." Provided in three outpatient appointments spaced approximately three weeks apart, bronchial thermoplasty has demonstrated five years of maintained therapeutic benefits, Dr. Bratis says. Pulmonologists use a bronchoscope to deliver controlled therapeutic radiofrequency energy to the smooth muscle in the airway. Heating the muscle prevents it A 1 5 - M I N UTE SC AN TO R ED U C E LU N G C AN C ER M O RTALIT Y RESULTS FROM A large-scale trial conducted by National Lung Screening Trial (NLST) researchers showed that compared with traditional X-rays, screening high-risk patients using low-dose CT scans reduced lung cancer mortality by 20 percent, notes William R. Burfeind Jr., MD, Chief of William R. Burfeind Jr., MD Thoracic Surgery at St. Luke's University Health Network. from contracting, which Dr. Stahlnecker explains is a major underlying problem associated with asthma. Minimally invasive bronchial thermoplasty aims to free patients with asthma from being tethered to their inhalers. "The hope is that patients will achieve an overall reduction in exacerbation rates," Dr. Stahlnecker says. "We think patients will require less rescue medication and perhaps even fewer maintenance medications after the third visit, when they'll reach their maximum benefit." SCREENING PARAMETERS The NLST study examined people between 55 and 74 years old who had smoked at least one pack of cigarettes a day for 30 years. Because the study conclusively proved lung cancer reduction in that group, St. Luke's University Health Network uses low-dose CT scans to screen patients who fall within the study's age and smoking history parameters. REDUCING THE DOSE Patients need a prescription from their primary care provider to undergo the scan. The scan takes 15 minutes and is performed Pulmonary Rehabilitation Although many of these diseases require significant levels of care and multidisciplinary expertise, some diseases may be treated effectively without hospitalization. Pulmonary rehabilitation may reverse the disease process in certain cases and eliminate the need for more intensive treatment. Owing to pulmonary rehabilitat ion's pre vent ive n at u re, Joh n Kintzer, MD, FCCP, pulmonary critical care specialist at St. Luke's University Health Network, board-certified in pulmonary and critical care medicine, considers it a vital adjunct to the Pulmonary Medicine Department's armamentarium of innovative treatments. "Pulmonary rehabilitation is an important component in treatment of patients with chronic lung disease," Dr. Kintzer at all St. Luke's University Health Network radiology locations. New software updates enable standard CT scanners to deliver fractional doses of radiation compared with normal chest CT scans: Low-dose CT scans deliver 1.5 mSv; standard scans deliver 4–6 mSv. The low radiation dosage makes for a repeatable scan. Dr. Burfeind recommends that people who fit NLST criteria and have a clear scan at age 55 be scanned annually until age 74. "Lung cancer screening is here," he says. "The data we have is so strong that this is a service that should be provided for at-risk patients, just like mammography and colonoscopy. We encourage patients to ask their primary care physician if it is right for them." For more information, call St. Luke's InfoLink at 1-866-STLUKES (785-8537). MDNEWS.COM I MD NEWS Eastern Pennsylvania/NW New Jersey | 13

